J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 4, Number 9, September 2013, pages 605-607


Breast Cancer Synchronism With Lung Cryptococcosis: A Case Report

Chun-Hung Lina, Chih-En Tsengb, e, Shu-Mei Changb, Moon-Sing Leec, e, Hon-Yi Linc, e, Yu-Chieh Sud, e, Wen-Yen Chiouc, e, Shih-Kai Hungc, e, f

aDepartment of General Surgery, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan
bDepartment of Anatomic Pathology, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan
cDepartment of Radiation Oncology, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan
dDepartment of Hematological Oncology, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan
eSchool of Medicine, Tzu Chi University, Hualian, 9706, Taiwan
fCorresponding author: Shih-Kai Hung, Department of Radiation Oncology, Buddhist Dalin Tzu Chi General Hospital, 2, Ming Sheng Road, Dalin, Chiayi, Taiwan

Manuscript accepted for publication July 18, 2013
Short title: Synchronism Cancer and Infection
doi: https://doi.org/10.4021/jmc1406w

Abstract▴Top 

Pulmonary metastasis is common among patients with breast cancer, and 18-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) is a useful diagnostic tool for identifying breast cancer with metastatic lesions. However, inflammation or infection can often interfere with diagnosis. We report on a 53-year-old female whose diagnosis included malignant breast cancer concurrent with lung cryptococcosis. A PET retention index greater than 10% has been used as a cutoff for malignancy; however, the retention index is not useful for differentiation if the initial standard uptake value is low. As such, a pathologic diagnosis should be considered.

Keywords: Breast cancer; Cryptococcosis; Positron emission tomography

Introduction▴Top 

Pulmonary metastasis is common among patients with breast cancer, especially in those at an advanced stage [1]. Chest computed tomography (CT) is the standard imaging modality used to evaluate pulmonary nodules [2]. With the development of modern techniques, 18-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) has become a useful tool for identifying breast cancer with metastatic lesions [3]. However, inflammation or infectious diseases can often interfere with the diagnosis [4]. In this report, we document a case of breast cancer concurrent with lung cryptococcosis and review the related literature.

Case Report▴Top 

A 53-year-old female patient was shown to have malignant breast cancer, as determined by excision biopsy. The patient was arranged to have a whole-body survey before radial surgery. Unfortunately, a lung mass was noted by CT. The patient then underwent PET/CT for further differential diagnosis. Following intravenous injection of 10 mCi F-18 FDG and a standard uptake period, the patient was imaged on a PET scanner and the images were reconstructed. PET/CT revealed a right breast nodule in accordance with pathology-approved malignancy (Fig. 1). In addition, PET/CT also revealed a nodule (19 mm) over the right lower lung (Fig. 2). The initial standard uptake value (SUV) of the right lower lung nodule was 1.7, the delay SUV was 2.5, and the retention index was 41%. Because the lung mass was solitary, we performed a partial mastectomy plus sentinel node for the breast lesion and wedge resection for the lung lesion after combined meeting. The pathology of the breast lesion indicated infiltrating ductal carcinoma, stage pT1cN1micM0. In addition, pathology of the lung lesion revealed positive staining for PAS, PASD, and mucicarmine and negative for acid fast staining. The sections showed lung tissue with a large caseating granuloma with abundant fungal elements. The morphology was that of cryptococcosis (Fig. 3). After final approved, the patient received sequent antibiotic therapy and adjuvant cancer therapy without incidence.

Figure 1.
Click for large image
Figure 1. PET/CT revealed a right breast nodule in accordance with pathology-approved malignancy.

Figure 2.
Click for large image
Figure 2. PET/CT revealed a nodule over the right lower lung.

Figure 3.
Click for large image
Figure 3. Pathology of the lung lesion revealed positive staining for mucicarmine.
Discussion▴Top 

Breast cancer is considered a systemic disease, and lung metastasis is common in these patients [1]. However, a series of studies have reported 5 - 22% of lung nodules are shown to be non-malignant following pathological confirmation [4-7]. Tanaka et al. evaluated 52 patients with breast cancer who underwent surgery for pulmonary nodules. The incidence of metastatic lesions, primary lung cancer, and non-malignancy was 61%, 17%, and 22%, respectively, for single lung nodules [4]. Because a single pulmonary nodule is not always a result of pulmonary metastasis, surgery is one option for obtaining pathologic confirmation.

An immunocompromised status caused by chemotherapy or tumor involvement may contribute to infection with malignancy. Cryptococcus infections have been reported in many patients with cancer, including those with nasopharyngeal carcinoma, leukemia, breast cancer, and lung cancer [7-10]. In addition, healthy persons with a history of exposure to pigeons have a higher rate of infection [11]. This is also true for patients that live in tropical climates and those who come in contact with the eucalyptus trees, with evidence indicating a significant prevalence in Taiwan [12]. Together, these factors may contribute substantially to the occurrence of cryptococcus infections.

Because pulmonary nodules mimic pulmonary metastases, obtaining an accurate diagnosis is important. PET is a useful and non-invasive tool for determining metastatic lesions, especially in lung, breast, and esophageal cancers [13]. Xiu et al. demonstrated that dual-time PET imaging can improve accuracy in the evaluation of lung nodules. A retention index greater than 10% has been used as a cutoff for determining malignancy [14]. However, Chen et al. showed that the retention index may not be useful for discrimination, especially if the initial standard uptake value is less than 2.5 [15]. Although the retention index was 41% in our case, the initial value of SUVmax was only 1.7. Thus, PET was not suitable for differentiating between malignant and benign disease in this patient.

Breast cancer with a single pulmonary nodule can be metastatic, primary, or benign and PET analysis can be used to differentiate between these states. However, PET is not useful for differentiation if the initial standard uptake value is low. In these cases, a pathologic diagnosis should be considered.

Conflict of Interest

The authors declare no conflicts of interest.


References▴Top 
  1. Rashid OM, Takabe K. The evolution of the role of surgery in the management of breast cancer lung metastasis. J Thorac Dis. 2012;4(4):420-424.
    pubmed
  2. Detterbeck FC, Grodzki T, Gleeson F, Robert JH. Imaging requirements in the practice of pulmonary metastasectomy. J Thorac Oncol. 2010;5(6 Suppl 2):S134-139.
    doi pubmed
  3. Brennan ME, Houssami N. Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer. Breast. 2012;21(2):112-123.
    doi pubmed
  4. Tanaka F, Li M, Hanaoka N, Bando T, Fukuse T, Hasegawa S, Wada H. Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg. 2005;79(5):1711-1714; discussion 1714-1715.
  5. Chang EY, Johnson W, Karamlou K, Khaki A, Komanapalli C, Walts D, Mahin D, et al. The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg. 2006;191(5):641-645.
    doi pubmed
  6. Casey JJ, Stempel BG, Scanlon EF, Fry WA. The solitary pulmonary nodule in the patient with breast cancer. Surgery. 1984;96(4):801-805.
    pubmed
  7. Ou KW, Hsu KF, Cheng YL, Hsu GC, Hsu HM, Yu JC. Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. Int J Infect Dis. 2010;14(1):e77-80.
    doi pubmed
  8. Sun LM, Chen TY, Chen WJ, Hsieh MJ, Liu JW, Huang CC, Wang CJ. Cryptococcus infection in a patient with nasopharyngeal carcinoma: imaging findings mimicking pulmonary metastases. Br J Radiol. 2002;75(891):275-278.
    pubmed
  9. Wells GM, Gajjar A, Pearson TA, Hale KL, Shenep JL. Brief report. Pulmonary cryptosporidiosis and Cryptococcus albidus fungemia in a child with acute lymphocytic leukemia. Med Pediatr Oncol. 1998;31(6):544-546.
    doi
  10. Kimura M, Kaufman L, Maekura S, Teramura K, Satou T, Hashimoto S. Pulmonary cryptococcosis due to a capsule-deficient strain confused with metastatic lung cancer. Mycopathologia. 1997;140(2):65-68.
    doi pubmed
  11. Newberry WM, Jr., Walter JE, Chandler JW, Jr., Tosh FE. Epidemiologic study of Cryptococcus neoformans. Ann Intern Med. 1967;67(4):724-732.
    doi pubmed
  12. Chen YC, Chang SC, Shih CC, Hung CC, Luhbd KT, Pan YS, Hsieh WC. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis. 2000;36(3):175-183.
    doi
  13. Visioni A, Kim J. Positron emission tomography for benign and malignant disease. Surg Clin North Am. 2011;91(1):249-266.
    doi pubmed
  14. Xiu Y, Bhutani C, Dhurairaj T, Yu JQ, Dadparvar S, Reddy S, Kumar R, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32(2):101-105.
    doi pubmed
  15. Chen CJ, Lee BF, Yao WJ, Cheng L, Wu PS, Chu CL, Chiu NT. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. AJR Am J Roentgenol. 2008;191(2):475-479.
    doi pubmed


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.